Lv4
620 积分 2022-11-07 加入
GPRC5D CAR T cells (OriCAR-017) in patients with relapsed or refractory multiple myeloma (POLARIS): a first-in-human, single-centre, single-arm, phase 1 trial
1个月前
已完结
Burden of metabolic diseases, 1990-2023, with forecasts to 2030 for the Asia-Pacific region
2个月前
已完结
Phase I Trial of MCARH109, a G Protein–Coupled Receptor Class C Group 5 Member D (GPRC5D)–Targeted Chimeric Antigen Receptor T-Cell Therapy for Multiple Myeloma: An Updated Analysis
2个月前
已完结
Chimeric antigen receptor T-cell therapy and bispecific antibody sequence for large B-cell lymphoma: a systematic review and meta-analysis
4个月前
已完结
Chimeric antigen receptor T-cell therapy and bispecific antibody sequence for large B-cell lymphoma: a systematic review and meta-analysis
4个月前
已完结
Large language model-based biological age prediction in large-scale populations
10个月前
已完结
ARID5A orchestrates cardiac aging and inflammation through MAVS mRNA stabilization
10个月前
已完结
Adverse cardiac events associated with antibody drug conjugates in cancer patients: a retrospective analysis on the FAERS database and randomized controlled trials
10个月前
已完结
Adverse cardiac events associated with antibody drug conjugates in cancer patients: a retrospective analysis on the FAERS database and randomized controlled trials
10个月前
已完结
Adverse cardiac events associated with antibody drug conjugates in cancer patients: a retrospective analysis on the FAERS database and randomized controlled trials
10个月前
已完结
皖公网安备34019202002308
